p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer
- 1 February 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (3) , 348-356
- https://doi.org/10.1016/s0959-8049(99)00271-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The p53 tumour suppressor geneBritish Journal of Surgery, 1998
- Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinomaInternational Journal of Cancer, 1997
- Apoptosis and immunohistochemicalbcl-2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significanceCancer, 1996
- Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survivalBritish Journal of Cancer, 1995
- bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomasHuman Pathology, 1995
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- The p53 tumour suppressor geneNature, 1991
- A genetic model for colorectal tumorigenesisCell, 1990
- Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Molecular and Cellular Biology, 1988